These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6165189)

  • 21. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
    Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
    J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy.
    Shephard SE; Langguth P; Panizzon RG
    Photodermatol Photoimmunol Photomed; 2001 Feb; 17(1):11-21. PubMed ID: 11169171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
    Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
    Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
    Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [5-Methoxypsoralen: bioavailability and pharmacokinetics].
    Nitsche V; Mascher H
    Arzneimittelforschung; 1982; 32(10):1338-41. PubMed ID: 6891237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H; Metz D
    Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
    [No Abstract]   [Full Text] [Related]  

  • 30. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans.
    Billard V; Gambus PL; Barr J; Minto CF; Corash L; Tessman JW; Stickney JL; Shafer SL
    Br J Clin Pharmacol; 1995 Oct; 40(4):347-60. PubMed ID: 8554937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy.
    van Coevorden AM; Kamphof WG; van Sonderen E; Bruynzeel DP; Coenraads PJ
    Arch Dermatol; 2004 Dec; 140(12):1463-6. PubMed ID: 15611423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].
    Nitsche V; Raff M; Bardach H
    Arch Dermatol Res; 1981; 271(1):11-7. PubMed ID: 7294879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
    Shephard SE; Zogg M; Burg G; Panizzon RG
    Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
    Leveque N; Muret P; Mary S; Bérard M; Makki S; Pierre Kantelip J; Humbert P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):119-27. PubMed ID: 12383487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
    Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraindividual variations of 8-methoxypsoralen plasma levels.
    Schäfer-Korting M; Korting HC
    Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and saliva levels of 8-methoxypsoralen after rectal administration as a micro-enema.
    Stolk L; Siddiqui AH; Kammeyer A; Cormane RH; van Zwieten PA
    Br J Dermatol; 1981 Apr; 104(4):447-51. PubMed ID: 7236508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.